Model
Edge
Lineage Cell Therapeutics
0001878732
Filing Type
4
Filing Date
2/12/2026
Updated
2/13/26, 5:30 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership